Aspirin provides adequate vte prophylaxis for patients undergoing hip preservation surgery, including periacetabular osteotomy

Basit Öğe Kaydı
dc.authorid0000-0003-0926-3029
dc.contributor.authorAzboy, İbrahim
dc.contributor.authorKheir, Michael M.
dc.contributor.authorHuang, Ronald
dc.contributor.authorParvizi, Javad
dc.date.accessioned10.07.201910:49:13
dc.date.accessioned2019-07-10T19:58:15Z
dc.date.available10.07.201910:49:13
dc.date.available2019-07-10T19:58:15Z
dc.date.issued2018
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Ortopedi ve Travmatoloji Ana Bilim Dalı
dc.descriptionWOS: 000449501200005
dc.descriptionPubMed ID: 29876128
dc.description.abstractThere are no dear guidelines regarding optimal venous thromboembolism (VTE) prophylaxis for patients undergoing hip preservation surgery (HPS), in particular pelvic osteotomy, which is considered to be a major orthopaedic procedure. The aim of this study was to determine the efficacy of aspirin for VTE prophylaxis in a large cohort of patients undergoing femoroacetabular osteoplasty (FAO) and periacetabular osteotomy (PAO). This was a retrospective study of prospectively collected data on patients undergoing HPS. A total of 603 patients (643 cases) underwent FAO and 80 patients (87 cases) underwent PAO between 2003 and 2016. The mean age of patients was 34.3 years (range 14.3-68.1 years). The type of VTE prophylaxis administered changed over time with earlier patients receiving warfarin (44 cases), followed by aspirin at 325 mg twice daily (448 cases), and most recently aspirin 81 mg twice daily (238 cases). The complications of symptomatic pulmonary embolism (PE), deep venous thrombosis (DVT) and major bleeding events within 90 days of surgery were documented. There were zero patients that developed major bleeding events or required evacuation of a hematoma. One patient who underwent FAO and received aspirin 325 mg, developed post-operative symptomatic DVT. One patient who underwent PAO and received aspirin 325 mg developed DVT and PE. This study demonstrates that the incidence of VTE following joint preservation procedure is acceptably low. Administration of aspirin to patients undergoing FAO or PAO appears to be adequate in reducing the risk of VTE. Only two patients in this cohort developed VTE following HPS.
dc.identifier.citationAzboy, İ., Kheir, M., Huang, R. ve Parvizi, J. (2018). Aspirin provides adequate vte prophylaxis for patients undergoing hip preservation surgery, including periacetabular osteotomy. Journal of Hip Preservation Surgery, 5(2), 125-130. https://dx.doi.org/10.1093/jhps/hny010
dc.identifier.doi10.1093/jhps/hny010
dc.identifier.endpage130
dc.identifier.issn2054-8397
dc.identifier.issue2
dc.identifier.startpage125
dc.identifier.urihttps://dx.doi.org/10.1093/jhps/hny010
dc.identifier.urihttps://hdl.handle.net/20.500.12511/3137
dc.identifier.volume5
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherOxford University Press
dc.relation.ispartofJournal of Hip Preservation Surgeryen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectDirect Anterior Approach
dc.subjectDeep-Vein Thrombosis
dc.subjectKnee Arthroplasty
dc.subjectVenous Thromboembolism
dc.subjectPrevention
dc.subjectThromboprophylaxis
dc.subjectEvents
dc.titleAspirin provides adequate vte prophylaxis for patients undergoing hip preservation surgery, including periacetabular osteotomy
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
Azboy, İ..pdf
Boyut:
279.34 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Makale Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu